DPP6 and Brugada syndrome: A similar observation in DPP6 is that administration of ajmaline (e.g. to rule out Brugada syndrome in IVF patients who were not yet identified as DPP6 carrier) may aggravate the phenotype and can result in short-coupled IVF (without signs of Brugada syndrome).